Capstone Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-76,200
Closed -$7.57M 1517
2019
Q3
$7.57M Buy
76,200
+5,600
+8% +$532K 0.05% 339
2019
Q2
$6.53M Sell
70,600
-118,700
-63% -$11.3M 0.05% 393
2019
Q1
$17.9M Buy
189,300
+156,600
+479% +$13.7M 0.16% 137
2018
Q4
$2.1M Buy
32,700
+10,100
+45% +$746K 0.03% 430
2018
Q3
$2.02M Buy
22,600
+13,200
+140% +$1.17M 0.02% 439
2018
Q2
$747K Buy
+9,400
New +$780K 0.01% 433
2018
Q1
Sell
-7,700
Closed -$803K 625
2017
Q4
$803K Hold
7,700
0.02% 213
2017
Q3
$1.12M Hold
7,700
0.04% 205
2017
Q2
$999K Sell
7,700
-1,900
-20% -$233K 0.03% 325
2017
Q1
$1.19M Sell
9,600
-1,800
-16% -$215K 0.03% 381
2016
Q4
$1.32M Buy
+11,400
New +$1.27M 0.04% 348

Other funds holding CELG

Capstone Investment Advisors's CELG Position: Q4 2019 in Review

Capstone Investment Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,342,761 shares — an estimated $133M sold.

Capstone Investment Advisors first reported a position in CELG in Q3 2013 and held it in 14 quarters. The position peaked at $133M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Capstone Investment Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Capstone Investment Advisors sold 1,342,761 Celgene Corp shares in Q4 2019, an estimated $133M.
  • Capstone Investment Advisors first reported a position in Celgene Corp in Q3 2013 and held it in 14 quarters.
  • Capstone Investment Advisors's Celgene Corp position peaked at $133M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Capstone Investment Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.